Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.
Market Data
Essential tool: analyze, trade, manage, decide.
What’s Your Call?
Collective community sentiment on Kimia Biosciences Ltd
Your Vote -
Buy
50.00%
Hold
0.00%
Sell
50.00%
50.00%
2 users have voted
Option Chain
Analyzes market sentiment, predicts Kimia Biosciences Ltd' movement.
NO_RECORD_FOUND
News
Media spotlight triggers stock stock attention, sentiment.
-
Kimia Biosciences - Shareholder Meeting / Postal Ballot-Scrutinizer's Report
-
Kimia Biosciences - Shareholder Meeting / Postal Ballot-Scrutinizer's Report
-
Kimia Biosciences - Shareholder Meeting / Postal Ballot-Scrutinizer's Report
-
Kimia Biosciences - Intimation-Change Of Scrutiniser Due To Unavailability-AGM On 30Th September 2025.
-
Kimia Biosciences - Shareholder Meeting / Postal Ballot-Outcome of AGM
-
Kimia Biosciences - Shareholder Meeting / Postal Ballot-Outcome of AGM
-
Kimia Biosciences - Board Meeting Outcome for Outcome Of Board Meeting Dated 29.08.2025
-
Kimia Biosciences - Board Meeting Intimation for Board Meeting To Be Held On Friday, August 29, 2025
-
Kimia Biosciences - Revised Outcome Of Board Meeting Dated 14.08.2025
-
Kimia Biosciences - Announcement under Regulation 30 (LODR)-Change in Management
-
Kimia Biosciences - Board Meeting Outcome for Board Meeting Outcome For Board Meeting Held Today On 14 Auguest,2025
-
Kimia Biosciences Q1 net profit down 58.33% at Rs 0.60 cr
-
Kimia Biosciences - Financial Results For The Quarter Ended June 30, 2025
-
Kimia Biosciences - Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29(1) Of SEBI (Listing Obligati
-
Kimia Biosciences - Disclosure under Regulation 30A of LODR
-
Kimia Biosciences - Disclosure under Regulation 30A of LODR
-
Kimia Biosciences - Shareholder Meeting / Postal Ballot-Scrutinizer\s Report
-
Kimia Biosciences has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2025
Key fundamentals
Evaluate the intrinsic value of Kimia Biosciences Ltd stock
| Name | March-24 | March-23 | March-22 | March-21 | March-20 |
|---|---|---|---|---|---|
| Assets | 49.5394 | 63.7096 | 55.5039 | 59.9092 | 44.0018 |
| Liabilities | 49.5394 | 63.7096 | 55.5039 | 59.9092 | 44.0018 |
| Equity | 4.7313 | 4.7313 | 4.7313 | 4.7313 | 4.6354 |
| Gross Profit | -0.4834 | -4.9759 | 0.6314 | 8.3787 | 4.4512 |
| Net Profit | -5.3087 | -9.3522 | -3.703 | 5.1043 | 1.381 |
| Cash From Operating Activities | 14.5348 | -6.77 | 0 | 5.967 | 0.3085 |
| NPM(%) | -5.06 | -7.27 | -2.96 | 3.84 | 1.29 |
| Revenue | 104.8765 | 128.516 | 124.9009 | 132.7138 | 106.2863 |
| Expenses | 105.3599 | 133.4919 | 124.2695 | 124.3351 | 101.8351 |
| ROE(%) | -53.26 | -93.84 | -37.15 | 51.21 | 13.85 |
Corporate Action
| XD-Date | Dividend-Amount | Dividend-% | Dividend Yield(%GE) | Price on that day |
|---|
Peers
Other companies within the same industry or sector that are comparable to Kimia Biosciences Ltd
| Company | Price | Price (% change) | pe(x) | EV/EBITDA(x) | ROE(%) | ROCE(%) |
|---|---|---|---|---|---|---|
| Albert David Ltd | 801.90 | 1.58 | 72.75 | 20.15 | 301.39 | 0.62 |
| Lotus Eye Hospital and Institute Ltd | 121.00 | -0.25 | 386.55 | 73.43 | 3.55 | 0.00 |
| Bharat Immunological and Biologicals Corporation Ltd | 21.06 | -0.09 | 0.00 | 152.47 | -39.50 | 0.00 |
| Astec Lifesciences Ltd | 764.25 | -0.95 | 0.00 | 69.25 | -604.77 | 0.00 |
Company Info
Laurel Organics Ltd. is a Public limited company, was incorporated in September 1993 in district Gurgaon, Haryana (India). 2017 NCLT approved the Scheme of Arrangement for Amalgamation of Kimia Biosciences Limited (Transferor Company) with Laurel Organics Limited (Transferee Company) 2019 -Company name has changed to Kimia Biosciences Ltd. from Laurel Organics Ltd.. 2024 -Kimia Biosciences Limited has been awarded a contract by a reputed client based in Europe. The Total Value of the Contract is USD 200,000/-
Laurel Organics Ltd. is a Public limited company, was incorporated in September 1993 in district Gurgaon, Haryana (India). 2017 NCLT approved the Scheme of Arrangement for Amalgamation of Kimia Biosciences Limited (Transferor Company) with Laurel Organics Limited (Transferee Company) 2019 -Company name has changed to Kimia Biosciences Ltd. from Laurel Organics Ltd.. 2024 -Kimia Biosciences Limited has been awarded a contract by a reputed client based in Europe. The Total Value of the Contract is USD 200,000/-
Read More
Parent Organisation
Kimia Biosciences Ltd.
Founded
27/09/1993
Managing Director
Mr.Sameer Goel
NSE Symbol
FAQ
The current price of Kimia Biosciences Ltd is
The 52-week high for Kimia Biosciences Ltd is
The market capitalization of Kimia Biosciences Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.
To buy Kimia Biosciences Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.
To invest in Kimia Biosciences Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Kimia Biosciences Ltd shares.
The CEO of Kimia Biosciences Ltd is Mr.Sameer Goel, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.
